A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients

Wai Lim, J.M. Eris, J. Kanellis, B.A. Pussell, Z. Wiid, D. Witcombe, G.R. Russ

    Research output: Contribution to journalArticle

    86 Citations (Scopus)

    Abstract

    This was a systematic review of randomized controlled trials comparing delayed conversion of mammalian target of rapamycin inhibitors (mTORi) for calcineurin inhibitors (CNIs) versus CNI continuation in kidney transplantation. Databases (2000-2012) and conference abstracts (2009-2012) were searched giving a total of 29 trials. Outcomes analyzed included GFR, graft loss, rejection and adverse events and were expressed as weighted mean differences (WMDs) or as risk ratios (RRs). Patients converted to mTORi up to 1 year posttransplant in intention-to-treat analysis had higher GFR compared with those remaining on CNI (WMD 0.28 mL/min/1.73 m2, 95% confidence interval [CI] 0.21-0.36; I2 = 68%, p <0.001). Stratifying trials by time posttransplant or type of mTORi did not change the overall heterogeneity. For on-treatment population, mTORi was associated with higher GFR (14.21 mL/min/1.73 m 2, 10.34-18.08; I2 = 0%, p = 0.970) 2-5 years posttransplant. The risk of rejection at 1 year was higher in mTORi trials (RR 1.72, 1.34-2.22; I2 = 12%, p = 0.330). Discontinuation secondary to adverse events was more common in patients on mTORi, whereas the incidence of skin cancers and cytomegalovirus infection was lower in patients on mTORi. Conversion from CNI to mTORi is associated with short-term improvements in GFR in a number of studies but longer-term follow-up data of graft and patient survival are required. This systematic review shows that conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitor after kidney transplantation is associated with short-term improvement in graft function despite a higher risk of early rejection. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.
    Original languageEnglish
    Pages (from-to)2106-2119
    JournalAmerican Journal of Transplantation
    Volume14
    Issue number9
    DOIs
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients'. Together they form a unique fingerprint.

    Cite this